ArticleDigestive diseases and sciences2022

Tofacitinib Appears Well Tolerated and Effective for the Treatment of Patients with Refractory Crohn's Disease.

Scott David Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.